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Abstract The purpose of this study was to evaluate
serum prolidase activity in patients with developmental
dysplasia of the hip (DDH). Prolidase enzyme activity was
measured spectrophotometrically to pointing out the col-
lagen metabolism. The prolidase activity in patients with
DDH was significantly higher than that in the control group
(p = 0.002). Furthermore, there was positive correlation
between prolidase activity and dysplasia level. Increased
serum prolidase activity may have played a role in the
presence of DDH. We therefore hypothesized that the
increased prolidase activity related to collagen turnover
may be associated with etiopathogenesis and/or the pro-
gression of the disease.
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Introduction
Developmental dysplasia of the hip (DDH) is a common
congenital abnormality that affects the developing hip joint
of the newborn. DDH is a comprehensive term used to
describe a spectrum of anatomical abnormalities of the hip
that may be congenital or may develop during infancy and/
or childhood. DDH refers to dysplasia of the acetabulum
(deficient development) or instability of the hip, such that
the femoral head can be partially or completely moved out
of the acetabulum [1].
The etiology of hip dysplasia is not clear, but this con-
dition does appear to be related to a number of different
factors. Female sex, being the first-born child and breech
positioning are all associated with an increased prevalence
of DDH. Other factors possibly related to DDH include
intrauterine positioning and sex, and some of these are
interrelated.
Anatomical abnormalities of the hip joint arose from a
deviation in normal hip to the developmental hip disorders
including partial or complete displacement of the femoral
head from acetabulum during infantile growth period [2]. It
has been thought that changes in the connective tissue of
joint capsule and ligaments might be responsible for the
increased laxity, although this association is less clear.
The hereditary disorders of connective tissues encom-
pass a spectrum of conditions linked pathophysiologically
by abnormalities of collagen, fibrillin and matrix proteins
[3, 4]. The last step of collagen degradation is mediated by
prolidase, which is a cytosolic exopeptidase that cleaves
iminodipeptides containing carboxyterminal proline or
hydroxyproline, and plays an important role in collagen
metabolism [5, 6]. The enzyme also recycles proline from
iminodipeptides derived from degradation products of
collagen and other proline-containing proteins. This
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recycling is important for collagen re-synthesis and cell
growth [7]. The relationship between collagen and proli-
dase activity was observed during fibrotic processes, where
an increase in prolidase activity was accompanied by
increase in tissue collagen deposition. In view of the above
facts, prolidase activity may be an important factor in the
regulation of collagen biosynthesis. Collagen is essential
for the maintenance of connective tissue [8, 9]. In various
studies, the aim was to associate collagen metabolism with
pathogenesis of the diseases of interest [10–13]. However,
to the best of our knowledge, there is no study in the
medical literature which is investigated prolidase activity
pointing out the collagen metabolism in DDH.
Materials and methods
Subjects
The study was conducted at the Harran University Medical
Faculty, Departments of orthopedic surgery and Clinical
Biochemistry during the years 2007 and 2008. Parents of
all patients signed informed consent forms approved the
study. Thirty-six patients (29 girls and 7 boys) were
included; three patients were bilaterally affected. Thirty-
three controls (22 girls and 11 boys) were included. A total
of 69 subjects between 9 and 18 months of age were
included. All patients were diagnosed as having typical
DDH.
Our patients had not undergone any operation before the
study. Cartilage metabolism may be influenced by the
operation. Secondary hip dislocations owing to neurologi-
cal pathologies were excluded from this study.
We used Tonnis’s [14] identification criteria for levels
of dysplasia of the hips, whereas radiological results
according to the Severin [15] scoring criteria. The control
groups were free of any medication for at least 4 weeks
prior to blood sampling. We performed all patients’ routine
hematological and biochemical parameters to exclude any
possible systemic disorder which may affect the parameters
used in the study.
Samples
Fasting blood samples were withdrawn and their sera were
separated with centrifugation at 3,000 rpm for 10 min, and
the serum samples were stored at -80 C until analysis.
Measurement of prolidase enzyme activity
Prolidase activity was determined by a photometric method
based on the measurement of proline levels produced by
prolidase [16–18]. The samples (100 lL) were mixed with
100 lL of serum physiological. A total of 25 lL of the
mixture was preincubated with 75 lL of the preincubation
solution (50 mmol/L Tris–HCl buffer pH 7.0 containing
1 mmol/L GSH, 50 mmol/L MnCl2) at 37 C for 30 min.
The reaction mixture, which contained 144 mmol/L gly-
pro, pH 7.8 (100 lL), was incubated with 100 lL of pre-
incubated sample at 37 C for 5 min. To stop the incuba-
tion reaction, 1 mL glacial acetic acid was added. After
adding 300 lL Tris–HCl buffer, pH 7.8 and 1 mL ninhy-
drin solution (3 g/dL ninhydrin was melted in 0.5 mol/L
orthophosphoric acid), the mixture was incubated at 90 C
for 20 min and cooled with ice. Absorbance was then
measured at a 515 nm wavelength in order to determine
proline by the method proposed by Myara et al. [19, 20],
which is a modification of Chinard’s method [21]. Intra-
and inter-assay coefficient of variations (CV) of the assay
were lower than 10 %.
Statistical analysis
All analyses were conducted using SPSS 11.5 (SPSS for
Windows 11.5, Chicago, IL). Continuous variables are
expressed as mean ± SD. The normality of distributions
was evaluated with the one-sample Kolmogorov–Smirnov
test. Student’s t test was used for group comparison. A two-
tailed p \ 0.05 was considered statistically significant.
Spearman’s correlation analysis was used to determine
magnitude of correlations between prolidase level and
Tonnis scores.
Results
The demographic and clinical data of the subjects are
summarized in Table 1. The average age were 12.5 ± 2.4
and 14 ± 2.4 months in patients and controls, respectively.
There were 29 girls and 7 boys in patients group and 22
girls and 11 boys in healthy controls. There were no sta-
tistically significant differences between the two groups
with regard to age and sex distribution.
The mean value of prolidase enzyme activity level was
575.11 ± 22.66 and 519.24 ± 9.99 IU in patients and
Table 1 Demographic and clinical data of the patients and controls
Patients Controls p
Case 36 33 [0.05




Prolidase (U/L) 575.11 ± 22.66 IU 519.24 ± 9.99 IU 0.001
Data are mean ± SD; [0.05 = non-significant
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controls, respectively. The prolidase level was significantly
higher in DDH patients than that in control group
(p \ 0.001) (Table 1). In addition, there was positive cor-
relation between prolidase activity and Tonnis scores in
patients with DDH (r = 0.44, p \ 0.001) (Table 2).
Discussion
The aim of our study was to associate collagen metabolism
with pathogenesis of the diseases of interest. We discov-
ered an interesting relationship between prolidase activity
and hip dysplasia. Increased prolidase activity may shed
light on the etiopathogenesis DDH.
Despite the intensive research, etiopathogenesis of DDH
is still poorly understood. Anatomical abnormalities of the
hip joint arose from a deviation in normal hip to the
developmental hip disorders including partial or complete
displacement of the femoral head from acetabulum during
infantile growth period [22]. Although in most affected
infants the problem resolves spontaneously in the first
several months of life, persisted DDH may result in chronic
pain and gait abnormalities [23]. In a typical synovial joint,
the ends of opposing bones are covered with a thin layer of
articular cartilage. Cartilage clearly performs a mechanical
function. It provides a bearing surface with low friction and
wear, and because of its compliance, it helps to distribute
the loads between opposing bones in a synovial joint. The
normal growth of the acetabulum depends on normal
epiphyseal growth of the triradiate cartilage and on the
three ossification centers located within the acetabular
portion of the pubis (os acetabulum), ilium (acetabular
epiphysis), and ischium [24].
Normal development of the hip joint requires appro-
priate alignment and contact between the ball of the fem-
oral head and the socket of the acetabulum. In persistent
DDH, the anatomical relationship between the femoral
head and the acetabulum is incorrect, leading to abnormal
development. In severe cases, a misplaced femoral head
leads to the development of a false acetabulum in the
pelvis. The relative influence of the collagen network and
proteoglycans on the tensile behavior of cartilage depends
on the rate of loading. When pulled at a slow rate, the
collagen network alone is responsible for the tensile
strength and stiffness of cartilage. At high rates of loading,
interaction between the collagen and proteoglycans is
responsible for the tensile behavior; proteoglycans restrain
the rotation of the collagen fibers when the tissue is loaded
rapidly. A delicate balance exists between the growing
proximal femur, the acetabular and tri-radiate cartilages
and adjacent bones that allow the acetabulum to develop. It
is not fully understood what controls this balance [24, 25]
and what factors are responsible for the degree of devel-
opment of a false acetabulum.
Abnormality in the shape of the acetabulum and femoral
head causes gait abnormalities. In DDH, the acetabulum is
too shallow and the head of the femur is insufficient; in
addition, there may be generalized joint laxity [23, 25]. It is
thought that the laxity of the capsule is a major contribu-
tory factor for DDH [26].
Biochemical studies of DDH capsules have been sug-
gested that the amount of type III collagen compared with
type I collagen is reduced and changes in cross-linking
occur. It was shown that increased proportion of type I
collagen to type III collagen (studies on prolidase defi-
ciency with a possible defect in collagen metabolism) was
related with increased prolidase activity. Serum prolidase
activity may be interpreted by increased collagen break-
down and turnover. Collagen and proteoglycans found in
the structure of joint cartilage. The increased prolidase
activity in patients with hip dysplasia implicates the
increased collagen breakdown and re-synthesis (collagen
turnover) [27, 28].
We found positive correlation between serum prolidase
activity and classification criteria for DDH. It appears that
prolidase level was affected with the severity of disease.
We also did not found any correlation between mean
prolidase activity and age, family history, disease duration.
Several limitations of this study should be considered.
The present work has a cross-sectional study design and it
has been undertaken on the small number of subjects. A
larger population studies are needed to elucidate whether
these alterations are consistent and have clinical relevance.
Another potential limitation of this study was the lack of
different age group patients with DDH. Future research on
the different clinical outcomes of DDH in the different age
group patients will further understanding of the etio-
pathogenesis of the disease and potentially provide a
rationale for targeted treatment interventions.
We thought that collagen metabolism, prolidase activity
and DDH might be associated with each other which may be
interpreted as evidence of increased collagen turnover in
DDH. To the best of our knowledge, there is no data con-
cerning the serum prolidase activity in subjects with DDH.
We think that more studies with larger case groups are nee-
ded to investigate serum prolidase activity and its relation
with collagen metabolism in the future. Initiation and pro-
gression of DDH remain to be evaluated with further studies.
Table 2 Association between prolidase level and Tonnis scores
Tonnis scores
Prolidase (U/L) r = 0.44, p \ 0.001
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